Patent · US Active

Liquid to liquid biological particle concentrator

US8110112B2 · kind B2 · utility

67Cited by
25References
38Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 30, 2008
Grant dateFeb 7, 2012
Priority date
Expiry dateJan 30, 2030

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2001/4088
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

A rapid one-pass liquid filtration system efficiently concentrates biological particles that are suspended in liquid from a dilute feed suspension. A sample concentrate or retentate suspension is retained while eliminating the separated fluid in a separate flow stream. Suspended biological particles include such materials as proteins/toxins, viruses, DNA, and/or bacteria in the size range of approximately 0.001 micron to 20 microns diameter. Concentration of these particles is advantageous for detection of target particles in a dilute suspension, because concentrating them into a small volume makes them easier to detect. Additional concentration stages may be added in “cascade” fashion, in order to concentrate particles below the size cut of each preceding stage remaining in the separated fluid in a concentrated sample suspension. This process can also be used to create a “band-pass” concentration for concentration of a particular target size particle within a narrow range.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.